Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Income from Continuing Operations for 6 consecutive years, with 3104628.0 as the latest value for Q4 2021.

  • Quarterly Income from Continuing Operations fell 37.94% to 3104628.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 11231250.0 through Dec 2021, up 4.22% year-over-year, with the annual reading at 7027410.0 for FY2025, 38.93% up from the prior year.
  • Income from Continuing Operations for Q4 2021 was 3104628.0 at ENDRA Life Sciences, down from 2658242.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 741623.0 in Q1 2017, with the low at 4809294.0 in Q4 2019.
  • Average Income from Continuing Operations over 5 years is 2571796.85, with a median of 2703489.0 recorded in 2019.
  • The sharpest move saw Income from Continuing Operations tumbled 280.96% in 2018, then skyrocketed 53.2% in 2020.
  • Over 5 years, Income from Continuing Operations stood at 2294640.0 in 2017, then dropped by 3.09% to 2365610.0 in 2018, then tumbled by 103.3% to 4809294.0 in 2019, then surged by 53.2% to 2250761.0 in 2020, then plummeted by 37.94% to 3104628.0 in 2021.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 3104628.0, 2658242.0, and 3199104.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.